Print
|
Strong Operational Quarter for the New Akzo Nobel
Financial Highlights
| EUR mln |
Q2 2007 |
Q2 2006 |
% change |
| Revenues Coatings / Chemicals |
2,685 |
2,624 |
2 |
| EBITDA* Coatings / Chemicals |
367 |
296 |
24 |
| EBITDA* margin, in % |
13.7 |
11.3 |
|
| EBIT* Coatings / Chemicals |
279 |
207 |
35 |
| EBIT* margin, in % |
10.4 |
7.9 |
|
| Net income* Coatings / Chemicals |
166 |
124 |
34 |
| Net income* Organon BioSciences |
146 |
121 |
21 |
| Total net income including incidentals |
270 |
361 |
(25) |
Highlights
- Improvement across the portfolio; EBITDA up 24%
- Active operational and margin management; EBITDA margin improved to 13.7%
- Excellent growth in DCoatings and Chemicals:
- Coatings - autonomous growth of 5%
- Chemicals - autonomous growth of 4%
- Net income (of Coatings and Chemicals) before incidentals up 34% to EUR 166 million
- Newly combined Decorative Coatings business starts visible turnaround
- Akzo Nobel's portfolio is well positioned for futher profitable growth
Arnhem, the Netherlands, July 24, 2007 - AKzo Nobel (Euronext Amsterdam: AKZ; Nasdaq: AKZOY) has reported a 24% improvement in EBITDA for the second quarter to EUR 367 million as the refocused company continues to realise the benefits of its global strategy.
More details
Highlights
Fit for the Future
-Report for the 2nd quarter of 2007
|
|
Printed from the Internet |
|